bluuebunny/crossref_metadata_2025_split huggingface dataset:
Prognostic competence as a criterion for the mental health of primary schoolchildren with psychological development disorders
Authors: Artemyeva T. , Akhmetzyanova A. , Mendelevich V. 
Published: September 2022

IntroductionYounger schoolchildren with psychological development disorders have low cognitive activity, insufficient development of basic school skills, and a low level of educational motivation. In accordance with the requirements of the educational program for students it is important to develop the ability to predict the results of their actions and deeds.ObjectivesThe study of predictive competence in primary schoolchildren with psychological development disorders.MethodsThe study involved 60 children aged 8-10 years with a psychological development disorder. To study predictive competence, the methodology “The ability to predict in situations of potential or real violation of social norms” was used.ResultsThe study revealed a low level of the cognitive and speech-communicative spheres of prognostic competence development in primary schoolchildren with psychological development disorders, as well as a deficit in prediction in the field of learning, which includes educational cooperation and educational communication of the child. Generalized statements, a passive position in future situations and pessimistic attitudes prevailed in the predictions of schoolchildren when constructing an image of the future. For schoolchildren the prognosis is presented by monosyllabic answers, with the observable poverty of speech utterances.ConclusionsThe features of prognostic competence revealed in the study make it possible to develop individual programs for the development of the prognostic abilities of schoolchildren with psychological development disorders, to teach how to predict the development of events in educational activities, to recognize the emotions of the participants in the events. This paper has been supported by the Kazan Federal University Strategic Academic Leadership Program.DisclosureNo significant relationships.
The impact of COVID-19 on mental health charity fundraising: An account from the perspective of fundraisers
Authors: Bartolome I. , Beezhold J. , Selwyn V. , Gilmore R. , Howard R. , Henderson N. 
Published: September 2022

IntroductionThe dawn of COVID-19 brought new rules, restrictions, and lockdowns but this led to the unlikely fall of many sectors, including the charitable sector. There has been a significant decline in funding received by mental health charities, especially during the pandemic. This study looks at the subsequent impact on fundraisers and mental health promotion during COVID-19.ObjectivesThe main aim was to uncover how the COVID-19 pandemic has affected the way that mental health charities fundraise, raise awareness, and promote mental health. This aimed to look at the impact of the COVID-19 pandemic on fundraisers supporting mental health charities and their opinion on whether fundraising has either helped or hindered mental health promotion.MethodsAccounts from fundraisers and local representatives for mental health charities during the COVID-19 pandemic were analysed. Common themes looked at the impact, adaptation, and reasons why fundraisers decided to help during a tough period for the charitable sector.ResultsMental health charities expressed difficulty in sourcing funds to support their users, especially in a vulnerable time. Fundraisers tried innovative ways to promote mental health and raise money for charities.ConclusionsAltruism and understanding how precious services such as mental health charities are for the population was the main driver for fundraisers. Mental health charities adapted by turning to online communication and reached out to fundraisers to continually highlight the importance of mental health to their users and fundraisers.DisclosureNo significant relationships.
“Permissiveness, guiltiness, anxiety”: A qualitative study on emotional meanings of school task procrastination reported by occupational therapy students in South-eastern Brazil
Authors: Turato E. , Santos E. 
Published: September 2022

IntroductionAccording to the Medical Subject Headings, the vocabulary used by PubMed, procrastination is ‘the deferment of actions or tasks to a later time, or to infinity’. Studies on procrastination are increasing, especially among university students, gaining prominence in academic literature. However, studies on the procrastination phenomenon have been mainly quantitative, correlating such experiences with clinical and behavioral manifestations. Specific research with occupational therapy students is lacking in the literature.ObjectivesTo interpret symbolic meanings related to life experiences of the procrastination phenomenon of school tasks as reported by occupational therapy undergraduate students, self-referred as procrastinators.MethodsClinical-qualitative design. Data collected through semi-directed interviews with open-ended questions in-depth. Clinical-Qualitative Content Analysis generated categories discussed in the light of the psychodynamic theoretical framework. This study was carried out in a private Brazilian university. The sample was closed by the information saturation criterion.ResultsSeven students were interviewed. Procrastination comes associated with anxiety as productivity, but not reported as an “executive drive”, that would imprison the individual in a vicious cycle. There are defense mechanisms referred to as self-preservation for not assume responsibilities for tasks. Ineffective strategies seem to be experienced by the students to avoid procrastination, but without resolving possible psychodynamic conflicts related to the task.ConclusionsStudents’ procrastination ambivalently affects their daily lives, although they can report the phenomenon as negative. It is suggested further qualitative studies that explore specifically meanings of procrastinating personal activities, in general, considering these individuals will work precisely in a therapeutic approach in the field of occupations of the people.DisclosureNo significant relationships.
Leukocyte elastase, a1-proteinase inhibitor, and autoantibodies to neuroantigens in diagnostics of endogenous depressive disorders
Authors: Sarmanova Z. , Subbotskaya N. , Zozulya S. , Barkhatova A. , Klyushnik T. 
Published: September 2022

IntroductionIt has been suggested that the activation of systemic inflammatory response in depression is associated with inflammatory changes in the brain (neuroinflammation) and may reflect the severity of the clinical symptoms in patients.ObjectivesTo study the relationship between clinical and immune parameters in patients with endogenous depressive disorders for the possible use of these indicators for diagnostics of these conditions.MethodsPatients with bipolar affective disorder (group 1) and recurrent depressive disorder (group 2) (F31, F32, F33) were examined before the therapy. Mentally healthy age- and gender-matched persons were investigated as controls. The severity of depressive symptoms was assessed by HDRS. The activity of inflammatory indicators (leukocyte elastase (LE) and 1-proteinase inhibitor (ɑ1-PI)), as well as the level of autoantibodies (AB) to S-100B and MBP, were measured in plasma.ResultsGroup 1 was characterized by an increase of LE and ɑ1-PI activity in comparison with the control group (р<0.001; р=0.002) and group 2 (р<0.05). No significant difference in AB to neuroantigens was found. Group 2 was distinguished by the increase in activity of the inflammatory indicators (р<0.01; р<0.05) as well as the autoimmune reactions to neuroantigens compared with control one (р=0.03). The correlations between complex assessment of the immune system and the severity of depressive symptoms in both groups were revealed (χ2=6.1; p=0.013; χ2=4.8; p=0.05).ConclusionsRevealed correlations suggest that inflammatory markers are involved in the pathogenesis of endogenous depressive disorders and can be used as an additional differential diagnostics criterion for the assessment of the clinical state of patients.DisclosureNo significant relationships.
Cycloid psychoses and autoimmunity: A case report of a patient with motility psychosis and Hashimoto’s thyroiditis
Authors: Lages Abrantes M. , Borja Santos J. 
Published: September 2022

IntroductionPsychotic episodes characterized by sudden onset of polymorphous psychotic symptoms and fast resolution have been a subject of interest of many psychiatrists throughout the History. Controversies about the diagnostic criteria and nomenclature of cycloid psychoses persist nowadays, what has hampered its study. In last years, several reports associating this disease with autoimmune pathologies have been published, revealing a possible association between them.ObjectivesTo contribute to the knowledge of cycloid psychoses, reporting a case of motility psychoses and exploring its possible association with autoimmune diseases.MethodsCase report and literature review.ResultsA 48-years-old woman presents a history of eleven admissions at the Psychiatry nursery in the last nineteen years, due to psychotic episodes. Usually, these episodes follow a default in psychopharmacological therapeutic, and are characterized by rapid onset of psychomotor agitation, with prominent nonpurpuseful exuberant movements, incoherent speech, mood oscillations and polythematic delusion. Between these decompensations, she recover her normal functioning, being medicated with lithium and an antipsychotic. During one of her admissions, at 2015, she developed fever and a stuporous state. The magnetic resonance and lumbar puncture were normal, the electroencephalogram revealed generalized lentification. Autoimmunity investigation evidenced positive antithyroid antibodies (with normal thyroid function) and the echography validated the diagnosis of Hashimoto’s thyroiditis.ConclusionsThis case report reveals a possible relationship between cycloid psychoses and Hashimoto’s thyroiditis. We need to share more knowledge to understand if it represents a comorbidity or a pathogenic process with the same etiology, what will influence the treatment of these patients.DisclosureNo significant relationships.
Children’s externalizing and internalizing symptoms and their involvement in decision-making
Authors: Németh B. , Miklósi M. 
Published: September 2022

IntroductionThe involvement of children in decision making processes was shown to have beneficial effects on their cognitive, emotional, and social development. However, no research focused on its association with child’s psychopathology.ObjectivesOur research aimed to explore the relationships between children’s externalizing and internalizing symptoms and their involvement in decision making in a dimensional approach.MethodsA community sample of 318 parents (64.2% mothers, mean age: 39.48 years SD=5.82) filled out an online questionnaire including the Decision-Making Involvement Scale (DMIS) assessing the parent’s and child’s behaviour in decision-making processes and the Strength and Difficulties Questionnaire (SDQ). Linear regression analyses were conducted for exploring multivariate associations of DMIS Parent and Child subscales with child’s psychopathology and prosocial behaviour, controlling for child’s gender and age.ResultsWith SDQ Internalizing problems subscale as dependent, linear regression analysis did not result in a significant model. In a significant model explaining 21.2% of the variance of the dependent variable, SDQ Externalizing problems score were significantly related to child’s age and gender, and to both Child and Parent subscales of the DMIS. When choosing SDQ Prosocial behaviour subscale as dependent, child’s gender and DMIS Child subscale were significantly associated to the dependent variables, accounting for 12.2% of the variance.ConclusionsOur results suggest that children’s involvement in decisions may be related to less externalizing symptoms and higher levels of prosocial skills. However, longitudinal research is needed to uncover the direction of the relationship and underlying mechanisms.DisclosureNo significant relationships.
Capgras and Fregoli delusions - a case report
Authors: Viseu M. , Tavares F. , Barbosa Pinto M. 
Published: September 2022

IntroductionCapgras and Fregoli delusions are psychotic complex conditions that integrate a larger group of Delusional Misidentification Syndromes (DMS), where the patient misidentifies people, places or objects.ObjectivesReview of the literature and exposure of a case report of a first psychotic episode with DMS.MethodsCase report and a nonsystematic review through databases. With the keywords: Capgras; Fregoli; DMS.ResultsThis case presents a caucasian male, 34-year-old, with no personal or family history of psychiatric pathology. He was taken to the emergency service, due to behavior disorder with verbal aggressiveness to his mother. During the psychiatric emergency he was restless, with accelerated speech and presented Capgras and Fregoli delusion. He believed that his mother had been replaced by an imposter and that the doctor was actually his childhood friend disguised, all with the intention of harming him. The patient was hospitalized, analytical and brain scan show no abnormally. Improvement in symptoms was been seen when a long-term injectable antipsychotic was started. The diagnosis was Bipolar type I disorder.ConclusionsDSM are more frequent than previously considered, they often occur in association with psychiatric or neurological disorders. Case reports like this one helps to clarify the association between DMS and psychiatric disorders. Given the high incidence of DMS, it is essential to recognize them, carry out an early treatment and be alert to other psychopathological or neurological symptoms that may coexist.DisclosureNo significant relationships.
Patients’ Satisfaction with the quality of online versus in-person DBT skills group therapy: A pilot study
Authors: Abdelkarim A. , Abdelfattah I. 
Published: September 2022

IntroductionSince the beginning of the COVID-19 era, there has been a major shift of psychiatry and psychotherapy practice to the online venues, or what has been broadly known as telepsychiatry. A practice that has been very practical since then. And yet, there has been a debate about the patients’ degree of satisfaction with the therapeutic process, especially with a modality like group therapy, which has not been widely researched.ObjectivesThe objective of this pilot is to assess the level of patients’ satisfaction among both online and in-person participants of dialectical behavioral therapy (DBT) skills group as a part of comprehensive outpatient DBT program.Methods27 DBT skills group participants completed an online form including demographic data, type and duration of group attended, in addition to the Arabic version of the Satisfaction with Therapy and Therapist Scale- Revised (STTS-R).ResultsThe majority of the 27 participants were females (88.9%), of which 81.4% were 18-34 years old and 77.4 % at least had a university degree. Among all the participants, 63% were online group attendants versus 37% in-person. The mean total of patient’s satisfaction with the in-person group was 53.5 in comparison to 49.2 in online group participants. Also, 90% of in-person group participants reported that the group helped them in dealing with presenting problem to an extent in comparison to 82.2% of online participants.ConclusionsAlthough the COVID-19 pandemic mandated more use of telepsychiatry, in-person DBT skills group participants reported higher satisfaction of their therapy in comparison to online group participants.DisclosureNo significant relationships.
Varenicline-induced sucidal behavior: Case report and literature review
Authors: Gutierrez Higueras T. , Calera Cortés F. , Sainz De La Cuesta Alonso S. , Vicent Forés S. , Hernández Gajate B. , Fiestas Velasco R.M. 
Published: September 2022

IntroductionNowdays there are different strategies for the treatment of smoking cessation. The treatment include drugs such as varenicline, which acts as a high-affinity partial agonist for the alpha-4 beta-2 nicotinic acetylcholine receptor subtype (nACh). We report a case of a suicidal behaviour in a 39 year-old woman with no previous history of mental illness, who was brought to the emergency department after intentional intoxication with benzodiazepines. The patient was on 10th day of treatment with varenicline.ObjectivesTo present a case of sucidal behavior that developed in a 39 year-old woman after starting varenicline. Review of literature and total number of cases reported in the european database of suspected adverse drug reactions (EudraVigilance).MethodsWe carried out a literature review in Pubmed electing those articles focused on mental disorders in those patients that have been taking varenicline. Review number of cases suicidal behavior reported by the European database of suspected adverse drug reactions.ResultsA 39-year-old female was brought to the emergency department after voluntary ingestion of Lorazepam 1mg (40 tablets) in a sucide attempt. The family reported the starting of thoughts of suicide after 1 week of treatment. No previous history of mental disorders. The patient reported low mood and drowsiness in the last 5 days not linked to any cause. After 5 days of discontinuation these mood symptoms and sucidal behavior remited.ConclusionsVarenicline is associated with different neuropsychiatric sypmtoms. In patients with or without history of mental disorders we should warn about the symptoms for discontinuation of the treatment.DisclosureNo significant relationships.
Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients
Authors: Shiri M. , Ouertani A. , Ouali U. , Jomli R. 
Published: September 2022

IntroductionClozapine is commonly associated with hematological side effects. However, little research is available on the impact of adding other psychotropic medication on inducing blood dyscrasias.ObjectivesThe aim of the study was to explore the impact of associating psychotropic medication to clozapine in producing hematological abnormalities.MethodsOur study was a longitudinal, retrospective chart review of adult psychiatric patients receiving clozapine treatment at our clozapine consultation between January 2000 and September 2020.ResultsOur sample consisted of 15 women (23.5%) and 49 men (76.5%), mean age was 41.34 ±9.32 years. Polypharmacy was found in 70.3% of the cases. Association of clozapine to other psychotropic agents was found in 67.2% of the cases. Most prescribed add-on medication was valproic acid in 27 cases, benzodiazepines in 21 cases, promethazine and hydroxyzine in 16 cases, lithium in 8 cases and haloperidol in 6 cases. We found blood dyscrasias in 21 patients (32.8%). Hematological abnormalities were as follow: 2 cases of agranulocytosis, 8 cases of neutropenia, 13 cases of thrombocytopenia, 5 cases of leukocytosis, 5 cases of eosinophilia and 3 cases of anemia. In our sample we did not find a significant association between psychotropic polypharmacy and blood dyscrasias.ConclusionsMany psychiatric patients on clozapine require polypharmacy to better stabilize their condition. Such co prescriptions may carry the risk of inducing more side effects especially blood dyscrasias. In our study, we did not find a significant association between psychotropic medication added to clozapine and hematological abnormalities. But further research is warranted to better explore this association.DisclosureNo significant relationships.
Aripiprazol and Hypersexuality: when partial is to much
Authors: Espada-Santos P. , Facucho-Oliveira J. , Mesquita B. , Fraga A. , Albuquerque M. , Costa M. , Marinho M. , Cintra P. 
Published: September 2022

IntroductionA growing number of published cases has showed that hypersexual behavior may arise with treatment with second-generation antipsychotics, including aripiprazole and olanzapine. Aripiprazole is a second-generation antipsychotic commonly used to treat schizophrenia and bipolar disorder. It has a unique pharmacologic profile acting as a partial agonist of the dopamine D2 receptor, as a partial agonist at the 5-HT1A receptor, and as an antagonist at the 5-HT2A receptor. Literature shows that medication with partial dopaminergic agonistic activity can cause compulsive behaviors, such as pathological gambling, compulsive eating, compulsive shopping, and hypersexuality. Although it is difficult to predict who would develop these behaviors, the literature suggests that patients at a higher risk of developing impulsive behaviors include those with a personal or family history of obsessive-compulsive disorder, impulse control disorder, bipolar disorder, impulsive personality, alcoholism, drug abuse, or other addictive behaviors.ObjectivesHere, we present a case of a 32-year-old male who developed hypersexuality symptoms after receiving aripiprazole as treatment for bipolar disorder.MethodsWe have done a literature review using the MeSH terms Aripiprazole and hypersexuality in the “PubMed”.ResultsAfter switching Aripiprazole to Risperidone the hypersexuality symptoms started to decrease and got almost complete relief after 2 weeks.ConclusionsThis case highlights the rare hypersexuality side effect that can arise in patients receiving aripiprazole for bipolar disorder treatment. Clinicians should be aware of the increased risk of hypersexuality and other impulsive behaviors as they can significantly impair a patient’s daily functioning.DisclosureNo significant relationships.
What is the Pisa Syndrome? A review
Authors: Santos H. , Dornelles E. , Pereira J. , Vieira A. 
Published: September 2022

IntroductionPisa syndrome (PS) is a type of dystonia of rare occurrence, first described in 1972 as an adverse effect of neuroleptic agents. It is used to describe a postural abnormality that includes trunk flexion in the coronal plane and axial rotation, which improves in the supine position.ObjectivesIn this work, we aim to conduct a brief review of Pisa Syndrome aetiology, pathophysiology and treatment.MethodsA non-systematic search was conducted through the PubMed database for “pisa syndrome”. Articles were screened for relevant information on PS aetiology, pathophysiology and treatment.ResultsPisa syndrome has been associated as an adverse effect of multiple drugs from different classes, mainly antipsychotics, dopaminergic agents and cholinesterase inhibitors. The underlying mechanisms are not yet fully understood. Nevertheless, one of the most consensual hypothesis considers PS as a consequence of a cholinergic-dopaminergic imbalance that can be caused by antipsychotic treatment. Some factors have been associated with increased risk for developing PS such as old age and polypharmacy. PS appears to be better treated with the reduction or interruption of the agent(s) associated with its onset.ConclusionsDespite its low incidence, Pisa syndrome can occur as a side effect of a number of different medications and the identification of the trigger-drug is fundamental so it can be reduced or interrupted in order to treat this condition.DisclosureNo significant relationships.